Naresh Tondare
Head – India and Nepal Regulatory Affairs
Glenmark Pharmaceuticals
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
http://www.glenmarkpharma.com/
12 years’ experience in Regulatory Affairs (India, India and Bhutan) and Global Clinical Regulatory Affairs (EU, ROWand India). Responsible for generic, branded generic and NCE products.
Responsible and accountable for Global CMC Regulatory Affairs (India, Nepal, Bhutan, Bangladesh and ROW markets), Global Clinical Regulatory Affairs (EU, US, ROW and India) and Regulatory Intelligence/strategy. Products include Complex Generics, Frist Generics, Generics, Novel Fixed Dose combinations (FDCs) New Drugs (India), Consumer Healthcare, OTC and New Chemical Entity (NCEs).
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…